Del (9q) AML: clinical and cytological characteristics and prognostic implications.

@article{Peniket2005DelA,
  title={Del (9q) AML: clinical and cytological characteristics and prognostic implications.},
  author={Andrew Peniket and J Stephen Wainscoat and Lucy E. Side and Sarah Daly and Rajko Ku{\vs}ec and Georgina A N Buck and Keith Wheatley and Helen Walker and Steve J Chatters and Christine J Harrison and Jacqueline Boultwood and Anthony Goldstone and Alan Burnett},
  journal={British journal of haematology},
  year={2005},
  volume={129 2},
  pages={210-20}
}
Del (9q) is a recurrent cytogenetic abnormality in acute myeloid leukaemia (AML). We report an analysis of 81 patients with del(9q) as a diagnostic karyotypic abnormality entered into the Medical Research Council AML trials 10, 11 and 12. Patients were divided into three groups: (i) Sole del (9q), 21 patients; (ii) Del(9q) in association with t(8;21), 29 patients; (iii) Del(9q) in association with other cytogenetic abnormalities, 31 patients. Sole del(9q) was associated with a characteristic… CONTINUE READING
15 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Similar Papers

Loading similar papers…